Kestra Medical Technologies, Ltd.
KMTS
$17.66
-$0.34-1.89%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 71.40% | 82.31% | 189.91% | 189.91% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 71.40% | 82.31% | 189.91% | 189.91% | |
| Cost of Revenue | 10.89% | 15.49% | 53.20% | 53.20% | |
| Gross Profit | 446.39% | 643.98% | 623.76% | 623.76% | |
| SG&A Expenses | 181.50% | 39.23% | 16.50% | 16.50% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 115.26% | 26.46% | 19.92% | 19.92% | |
| Operating Income | -136.93% | -3.28% | 16.09% | 16.09% | |
| Income Before Tax | -128.63% | -0.63% | 18.44% | 18.44% | |
| Income Tax Expenses | 477.78% | 28.57% | -59.46% | -59.46% | |
| Earnings from Continuing Operations | -129.36% | -0.65% | 18.47% | 18.47% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -133.59% | 0.51% | 19.84% | 19.84% | |
| EBIT | -136.93% | -3.28% | 16.09% | 16.09% | |
| EBITDA | -175.28% | -12.84% | 16.85% | 16.85% | |
| EPS Basic | -84.39% | -5.98% | 13.50% | 13.50% | |
| Normalized Basic EPS | -106.96% | 1.21% | 16.10% | 16.10% | |
| EPS Diluted | -84.39% | -5.98% | 13.50% | 13.50% | |
| Normalized Diluted EPS | -106.96% | 1.21% | 16.10% | 16.10% | |
| Average Basic Shares Outstanding | 23.63% | 0.00% | 0.00% | 0.00% | |
| Average Diluted Shares Outstanding | 23.63% | 0.00% | 0.00% | 0.00% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |